uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted June 22, 2017

FDA Finds Hidden Drug Ingredients in Sexual Enhancement Supplements

On June 22, 2017, the FDA warned consumers that the following sexual enhancement supplements were found to contain undeclared sildenafil, tadalafil and/or dapoxetine. Use the links below to read the complete warning letter for each: Sildenafil, the active ingredient in the prescription drug Viagra, and tadalafil, the active ingredient in Cialis, are prescribed for erectile dysfunction. These drugs can cause symptoms like headache and flushing, and can interact with medications containing nitrates such as nitroglycerine, resulting in dangerously low blood pressure. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) which is not approved by the FDA; its safety and efficacy are unknown. SSRI drugs can increase the risk of suicidal thinking and behavior in children, adolescents, and young adults and should not be taken without a prescription and physician supervision.

Consumers who have purchased these supplements should not use them and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See related warnings:

Sexual Enhancement Supplements Found to Contain Drugs

Sexual Enhancement Supplements for Men and Women Recalled

Twenty-one Sexual Enhancement Products Recalled

Twelve Sexual Enhancement Supplements Found to Contain Prescription Drug

To learn more about Medication Health Fraud, click the link below: